Chondrocytes are specialised cells that are essential for cartilage maintenance and repair, and their dysfunction is central to the development of joint diseases like osteoarthritis (OA). However, the cell heterogeneity of chondrocytes in human articular cartilage is still not well defined, which hinders understanding of the pathogenesis of OA.
This research, published in the Genes & Diseases journal by a team from the Harbin Institute of Technology, Southern University of Science and Technology, Shenzhen University, Guangxi University of Chinese Medicine, Guangdong Medical University, and the University of Chinese Academy of Sciences, employs Single-cell RNA sequencing (scRNA-seq) to uncover distinct subpopulations of human tissue chondrocytes (HTC).

The researchers used scRNA-seq to construct a single-cell transcriptomic atlas of chondrocytes in healthy human cartilage, identifying two HTC subpopulations, namely HTC-1 and HTC-2. HTC-1, the novel THC subset, specifically expressed genes associated with cell apoptosis and programmed cell death and was found to be expressed more in the cartilage of OA patients compared with healthy individuals. This finding indicates that an increased presence of HTC-1 and decreased chondrocyte apoptosis play pivotal roles in the pathogenesis of OA.

In addition to HTC-1, the researchers also identified a significant expansion of population size in proliferate fibrochondrocytes (ProFC), especially a newly discovered subset, namely ProFC-2, in OA cartilage. Different from ProFC, ProFC-2 showed a heightened inflammatory response, and increased cytokine signalling and cellular responses to stimuli. Thus, ProFC-2 is an OA cartilage-specific subpopulation and may contribute to the development of OA via inflammation.

This study also highlights homeostatic chondrocytes (HomC), a subpopulation known for its pronounced expression of human circadian clock rhythm genes and protective effects against cartilage degeneration. Interestingly, the researchers found that HomC expression was significantly lower in OA cartilage compared to healthy cartilage, providing new insights into the molecular mechanisms of OA.

The key findings of this study include the identification of HTC-1, a subpopulation involved in apoptosis, and the discovery of an OA-specific ProFC-2, linked to inflammatory processes. A comparison of chondrocyte subsets between healthy cartilage and OA cartilage showed that ProFC and HTC-1 populations expanded in OA patients, whereas the HomC population decreased. This study deepens our understanding of chondrocyte heterogeneity in articular cartilage and thereby provides valuable clues about the cellular mechanisms driving the development and progression of OA. In conclusion, the researchers highlight that these insights could pave the way for future therapeutic approaches aimed at modulating chondrocyte populations and preventing cartilage degeneration in OA.

Reference

Title of Original Paper: Single-cell transcriptomic analysis of chondrocytes in cartilage and pathogenesis of osteoarthritis
DOI: https://doi.org/10.1016/j.gendis.2024.101241
Journal: Genes & Diseases
Genes & Diseases is a journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch.

Funding Information:

National Key R&D Program of China (No. 2021YFF1200900)
National Natural Science Foundation of China (No. 32170646, 8197211)
Guangdong Basic and Applied Basic Research Foundation (China) (No. 2023A1515011908)
Key-Area Research and Development Program of Guangdong Province, China (No. 2023B1111020006)
International Science and Technology Cooperation Program of Guangdong, China (No. 2021A0505030011)
Shenzhen Innovation Committee of Science and Technology (Guangdong, China) (No. JCYJ20220818100401003)
Shenzhen Science and Technology Program (Guangdong, China) (No. SGDX20201103095800003, GJHZ20200731095606019, JCYJ20220818100401003)
Shenzhen High-level Hospital Construction Fund (Guangdong, China) (No. 1801004)

# # # # # #

Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.

Scopus CiteScore: 7.3 | Impact Factor: 6.9

# # # # # #

More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/

Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/

All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases).

Submissions to Genes & Disease may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx ).

Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.com

X (formerly Twitter): @GenesNDiseases (https://x.com/GenesNDiseases )
# # # # # #